Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 11 studies | 23% ± 4% | |
lung | 10 studies | 29% ± 12% | |
intestine | 6 studies | 26% ± 13% | |
kidney | 5 studies | 26% ± 6% | |
brain | 5 studies | 27% ± 7% | |
eye | 5 studies | 27% ± 11% | |
lymph node | 4 studies | 24% ± 5% | |
pancreas | 3 studies | 34% ± 4% | |
bone marrow | 3 studies | 24% ± 7% | |
breast | 3 studies | 19% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 7086.74 | 1445 / 1445 | 100% | 162.95 | 183 / 183 |
liver | 100% | 5012.85 | 226 / 226 | 100% | 121.90 | 406 / 406 |
ovary | 100% | 7435.23 | 180 / 180 | 100% | 285.92 | 430 / 430 |
thymus | 100% | 16166.13 | 653 / 653 | 100% | 303.20 | 605 / 605 |
brain | 100% | 8386.83 | 2641 / 2642 | 100% | 244.62 | 705 / 705 |
uterus | 100% | 7527.41 | 170 / 170 | 100% | 161.18 | 458 / 459 |
skin | 100% | 6356.34 | 1809 / 1809 | 100% | 150.83 | 470 / 472 |
adrenal gland | 100% | 6736.55 | 258 / 258 | 100% | 170.88 | 229 / 230 |
pancreas | 100% | 5060.84 | 328 / 328 | 99% | 152.55 | 177 / 178 |
intestine | 100% | 7040.51 | 966 / 966 | 99% | 148.40 | 524 / 527 |
prostate | 100% | 8479.78 | 245 / 245 | 99% | 181.09 | 499 / 502 |
kidney | 100% | 8417.74 | 89 / 89 | 99% | 129.37 | 894 / 901 |
stomach | 100% | 6570.42 | 359 / 359 | 99% | 153.13 | 282 / 286 |
breast | 100% | 8594.44 | 459 / 459 | 98% | 132.16 | 1100 / 1118 |
lung | 100% | 7177.09 | 577 / 578 | 98% | 135.67 | 1132 / 1155 |
bladder | 100% | 7240.95 | 21 / 21 | 97% | 156.85 | 490 / 504 |
adipose | 100% | 7463.56 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 148.52 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 143.98 | 29 / 29 |
spleen | 100% | 8276.20 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 151.67 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 192.00 | 1 / 1 |
blood vessel | 100% | 9664.55 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 5041.17 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 100% | 7854.14 | 858 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 100% | 5154.32 | 925 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0044070 | Biological process | regulation of monoatomic anion transport |
GO_2000008 | Biological process | regulation of protein localization to cell surface |
GO_0032456 | Biological process | endocytic recycling |
GO_0071468 | Biological process | cellular response to acidic pH |
GO_0032402 | Biological process | melanosome transport |
GO_0035773 | Biological process | insulin secretion involved in cellular response to glucose stimulus |
GO_0045055 | Biological process | regulated exocytosis |
GO_0090150 | Biological process | establishment of protein localization to membrane |
GO_0150093 | Biological process | amyloid-beta clearance by transcytosis |
GO_0033572 | Biological process | transferrin transport |
GO_0045054 | Biological process | constitutive secretory pathway |
GO_0001881 | Biological process | receptor recycling |
GO_2001135 | Biological process | regulation of endocytic recycling |
GO_0055037 | Cellular component | recycling endosome |
GO_0030672 | Cellular component | synaptic vesicle membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0055038 | Cellular component | recycling endosome membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005829 | Cellular component | cytosol |
GO_0008021 | Cellular component | synaptic vesicle |
GO_0045335 | Cellular component | phagocytic vesicle |
GO_0030670 | Cellular component | phagocytic vesicle membrane |
GO_0019003 | Molecular function | GDP binding |
GO_0045296 | Molecular function | cadherin binding |
GO_0003925 | Molecular function | G protein activity |
GO_0031489 | Molecular function | myosin V binding |
GO_0005525 | Molecular function | GTP binding |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | RAB11B |
Protein name | Ras-related protein Rab-11B (EC 3.6.5.2) (GTP-binding protein YPT3) RAB11B, member RAS oncogene family |
Synonyms | YPT3 |
Description | FUNCTION: The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different set of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion. The small Rab GTPase RAB11B plays a role in endocytic recycling, regulating apical recycling of several transmembrane proteins including cystic fibrosis transmembrane conductance regulator/CFTR, epithelial sodium channel/ENaC, potassium voltage-gated channel, and voltage-dependent L-type calcium channel. May also regulate constitutive and regulated secretion, like insulin granule exocytosis. Required for melanosome transport and release from melanocytes. Also regulates V-ATPase intracellular transport in response to extracellular acidosis. Promotes Rabin8/RAB3IP preciliary vesicular trafficking to mother centriole by forming a ciliary targeting complex containing Rab11, ASAP1, Rabin8/RAB3IP, RAB11FIP3 and ARF4, thereby regulating ciliogenesis initiation (Probable). On the contrary, upon LPAR1 receptor signaling pathway activation, interaction with phosphorylated WDR44 prevents Rab11-RAB3IP-RAB11FIP3 complex formation and cilia growth (Probable). . |
Accessions | ENST00000328024.11 [Q15907-1] M0R377 Q15907 M0R2D0 ENST00000601897.1 ENST00000600719.5 ENST00000594216.1 [Q15907-2] |